Literature DB >> 30406369

How to improve response to rituximab treatment in children with steroid-dependent nephrotic syndrome: answer to Drs. Fujinaga and Nishino.

Julien Hogan1, Georges Deschenes2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30406369     DOI： 10.1007/s00467-018-4133-x

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN： 0931-041X            Impact factor:   3.714


× No keyword cloud information.
  3 in total

1.  Autoantibodies against podocytic UCHL1 are associated with idiopathic nephrotic syndrome relapses and induce proteinuria in mice.

Authors:  Agnès Jamin; Laureline Berthelot; Anne Couderc; Jonathan M Chemouny; Erwan Boedec; Laurène Dehoux; Lilia Abbad; Claire Dossier; Eric Daugas; Renato C Monteiro; Georges Deschênes
Journal:  J Autoimmun       Date:  2018-01-04       Impact factor: 7.094

2.  B Cell Reconstitution after Rituximab Treatment in Idiopathic Nephrotic Syndrome.

Authors:  Manuela Colucci; Rita Carsetti; Simona Cascioli; Federica Casiraghi; Annalisa Perna; Lucilla Ravà; Barbara Ruggiero; Francesco Emma; Marina Vivarelli
Journal:  J Am Soc Nephrol       Date:  2015-11-13       Impact factor: 10.121

3.  Effect of different rituximab regimens on B cell depletion and time to relapse in children with steroid-dependent nephrotic syndrome.

Authors:  Julien Hogan; Claire Dossier; Thérésa Kwon; Marie-Alice Macher; Anne Maisin; Anne Couderc; Olivier Niel; Véronique Baudouin; Georges Deschênes
Journal:  Pediatr Nephrol       Date:  2018-08-14       Impact factor: 3.714
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.